The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The role of IGF-1R in EGFR TKI resistance in NSCLC using IHC and AQUA technology.
Y. Kato
No relevant relationships to disclose
C. Mascaux
No relevant relationships to disclose
M. W. Wynes
No relevant relationships to disclose
B. Reyna Asuncion
No relevant relationships to disclose
C. Tran
No relevant relationships to disclose
K. Yoshida
No relevant relationships to disclose
J. Matsubayashi
No relevant relationships to disclose
E. Nakajima
No relevant relationships to disclose
T. Ohira
No relevant relationships to disclose
T. Nagao
No relevant relationships to disclose
K. Furukawa
No relevant relationships to disclose
N. Ikeda
No relevant relationships to disclose
F. R. Hirsch
No relevant relationships to disclose